Daniel Szerman

Daniel Szerman currently serves as the Finance Director Germany at Idorsia Pharmaceuticals Ltd, where he plays a pivotal role in shaping the financial strategy and operational excellence of the German subsidiary. As a key member of the management team, Daniel oversees the finance department, which encompasses financial accounting, liquidity management, and sales controlling, ensuring that all financial activities align with the company's strategic objectives. His expertise in financial planning and analysis enables him to provide critical insights that support decision-making at the executive level, fostering sustainable growth in a highly competitive pharmaceutical landscape.

In his role, Daniel acts as a strategic sparring partner for the Managing Director and collaborates closely with cross-functional teams across sales, R&D, and commercial operations. His deep understanding of the life sciences and pharma industries, combined with his entrepreneurial mindset, allows him to navigate complex regulatory environments and market dynamics effectively. Daniel’s leadership extends beyond day-to-day financial management; he is instrumental in driving organizational development initiatives, optimizing financial processes, and implementing innovative solutions to enhance operational efficiency.

With over 15 years of professional experience, including more than 7 years in CFO roles, Daniel has a proven track record in M&A, organizational building, and managing cross-location teams. His ability to lead a diverse team of 35 professionals across multiple companies demonstrates his strong management skills and strategic vision. As a Group CFO with responsibility for triple-digit million sales, Daniel Szerman brings a comprehensive understanding of financial analytics, corporate strategy, and business partnering—making him a vital driver of Idorsia’s growth and success in the German market.